NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") (NASDAQ:VKTX). Such investors are ...
Justin Zelin, an analyst from BTIG, reiterated the Buy rating on Mersana Therapeutics (MRSN – Research Report). The associated price ...
SAN DIEGO—Matthew Singleton, a director at Viking Therapeutics, Inc. (NASDAQ:VKTX), recently executed a significant stock sale, according to a filing with the Securities and... ByInvesting.com ...
While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...
One dedicated fan and hardworking nurse is getting a special treat, thanks to a partnership between Dunkin' and UGA Athletics ...
Be Nutty: “Nuts are an excellent choice for controlling inflammation,” say experts at the University of North Carolina. “They ...
PHILADELPHIA--The National Disease Research Interchange (NDRI) is proud to announce that Pennsylvania Governor Josh Shapiro ...
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced ...